Older People More Prone to Relocating After Dementia Diagnosis
By Ernie Mundell HealthDay Reporter
THURSDAY, Oct. 17, 2024 -- A new diagnosis of Alzheimer's or other dementia often spurs a person to move from their home, new research shows.
“One possible explanation is that individuals with dementia and their caregivers may choose to move closer to family or informal caregivers, either with independent housing arrangements or entering formal long-term care services,” wrote a team led by Momotazur Rahman, an associate professor of health services, policy and practice at Brown University in Providence, R.I.
The study was published Oct. 14 in the journal JAMA Network Open.
The researchers used Medicare data on the residential histories of over 1.6 million Medicare beneficiaries. All had received a diagnosis of either dementia, heart attack, chronic obstructive pulmonary disease (COPD) or colon cancer in 2016.
Each person's domicile (including nursing homes) was tracked over the eight years before and after the 2016 diagnosis -- 2012 through 2020.
In the four years before a dementia diagnosis, there was no difference observed in where people lived or whether they relocated, the study found.
However, within the four years of a dementia diagnosis, 22% of people moved to a different U.S. county, Rahman's group found. That's a 40% jump in relocations compared to folks who'd been diagnosed with other conditions, such as heart attack or COPD.
People with a dementia diagnosis were also more likely to move to another state, the study found. In most cases, they simply moved to another house, rather than to a nursing home.
“Our findings illuminate the profound impact that a dementia diagnosis can have on an individual’s residential choices, challenging traditional conceptions of aging in place and adding depth to our understanding of the interplay between health and migration,” the researchers said in a American Psychiatric Association news release.
The new data could have implications for aging populations.
“As the global population ages and dementia prevalence increases, it becomes crucial for policymakers and communities to recognize and address the unique migration patterns and needs of individuals with this life-altering condition," they wrote.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-18 06:00
Read more
- Vitamin D Supplements Could Help Lower Blood Pressure in Obese People
- COVID-19 Pandemic-Linked Increase in Alcohol Use Persisting
- Adverse Events Occur in More Than One-Third of Patients Admitted for Surgery
- AHA: Intensive Strategy for Lowering Systolic BP Beneficial in Type 2 Diabetes
- JAMA Oncology Publishes Phase 1b/2 Study Data on IASO Bio's Equecabtagene Autoleucel (Fucaso™) in the Treatment of Relapsed/Refractory Multiple Myeloma
- Linerixibat Shows Positive Phase III Results in Cholestatic Pruritus in Primary Biliary Cholangitis (PBC)
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions